1. Complete response to CSF1R inhibitor in a translocation variant of teno-synovial giant cell tumor without genomic alteration of the CSF1 gene. (14th April 2018) Authors: Brahmi, M; Alberti, L; Tirode, F; Karanian, M; Eberst, L; Pissaloux, D; Cassier, P; Blay, J Y Journal: Annals of oncology Issue: Volume 29:Number 6(2018) Page Start: 1488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. JS1.1 Specific genetic alterations of breast tumors lead to Yo paraneoplastic cerebellar syndromes. (6th September 2019) Authors: Desestret, V; Pissaloux, D; Treilleux, I; Small, M; Robert, M; Rogemond, V; Picard, G; Psimaras, D; Alentorn, A; Honnorat, J Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii4 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular screening program to select molecular-based recommended therapies for metastatic cancer patients: analysis from the ProfiLER trial. (13th March 2019) Authors: Trédan, O; Wang, Q; Pissaloux, D; Cassier, P; de la Fouchardière, A; Fayette, J; Desseigne, F; Ray-Coquard, I; de la Fouchardière, C; Frappaz, D; Heudel, P -E; Bonneville-Levard, A; Fléchon, A; Sarabi, M; Guibert, P; Bachelot, T; Pérol, M; You, B; Bonnin, N; Collard, O Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 757 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P14.127 From next generation sequencing and comparative genomic hybridization to personalised medicine for adult primary brain tumors: the profiler trial. (6th September 2019) Authors: Bonneville-levard, A; Frappaz, D; Pissaloux, D; Wang, Q; Perol, D; Blay, J; Meyronet, D Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 3 Page Start: iii99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗